Chiron news

Increased revenues came principally from increased products sales in CHIR's oncology and ophthalmics businesses, increased collaborative research revenues, and increased revenues from its share of the profit from its joint blood screening and diagnostics business with Ortho Diagnostic Systems Inc. ...